Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May;131(5):405-408.
doi: 10.1007/s00702-024-02763-5. Epub 2024 Mar 16.

Neuroscience and addiction research: current advances and perspectives

Affiliations
Editorial

Neuroscience and addiction research: current advances and perspectives

Emmanuel Darcq et al. J Neural Transm (Vienna). 2024 May.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Agarwal K, Manza P, Chapman M, Nawal N, Biesecker E, McPherson K, Dennis E, Johnson A, Volkow ND, Joseph PV (2022) Inflammatory markers in Substance Use and Mood disorders: a neuroimaging perspective. Front Psychiatry 13:863734. https://doi.org/10.3389/fpsyt.2022.863734 - DOI - PubMed - PMC
    1. Beaulieu M, Tremblay J, Baudry C, Pearson J, Bertrand K (2021) A systematic review and meta-analysis of the efficacy of the long-term treatment and support of substance use disorders. Soc Sci Med 285:114289. https://doi.org/10.1016/j.socscimed.2021.114289 - DOI - PubMed
    1. Brown JW (2023) Transcranial Electrical Neurostimulation as a potential addiction treatment. Inquiry 60:469580231221286. https://doi.org/10.1177/00469580231221286 - DOI - PubMed
    1. Browne CJ, Godino A, Salery M, Nestler EJ (2020) Epigenetic mechanisms of opioid addiction. Biol Psychiatry 87(1):22–33. https://doi.org/10.1016/j.biopsych.2019.06.027 - DOI - PubMed
    1. Charbogne P, Kieffer BL, Befort K (2014) 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacol 76 Pt B 0 0204–217. https://doi.org/10.1016/j.neuropharm.2013.08.028

Publication types